190 related articles for article (PubMed ID: 22987266)
1. [Coagulase-negative Staphylococcus bacteraemia: prognosis factors and influence of antibiotic treatment].
Fernández-Rufete A; García-Vázquez E; Hernández-Torres A; Canteras M; Ruiz J; Gómez J
Rev Esp Quimioter; 2012 Sep; 25(3):199-205. PubMed ID: 22987266
[TBL] [Abstract][Full Text] [Related]
2. Impact of antibiotic resistance and of adequate empirical antibiotic treatment in the prognosis of patients with Escherichia coli bacteraemia.
Peralta G; Sánchez MB; Garrido JC; De Benito I; Cano ME; Martínez-Martínez L; Roiz MP
J Antimicrob Chemother; 2007 Oct; 60(4):855-63. PubMed ID: 17644532
[TBL] [Abstract][Full Text] [Related]
3. Unusually virulent coagulase-negative Staphylococcus lugdunensis is frequently associated with infective endocarditis: a Waikato series of patients.
Liang M; Mansell C; Wade C; Fisher R; Devlin G
N Z Med J; 2012 May; 125(1354):51-9. PubMed ID: 22595924
[TBL] [Abstract][Full Text] [Related]
4. Clinical characterization of breakthrough bacteraemia: a survey of 392 episodes.
López Dupla M; Martinez JA; Vidal F; Almela M; López J; Marco F; Soriano A; Richart C; Mensa J
J Intern Med; 2005 Aug; 258(2):172-80. PubMed ID: 16018794
[TBL] [Abstract][Full Text] [Related]
5. The species distribution, antimicrobial resistance and risk factors for poor outcome of coagulase-negative staphylococci bacteraemia in China.
Cui J; Liang Z; Mo Z; Zhang J
Antimicrob Resist Infect Control; 2019; 8():65. PubMed ID: 31044070
[TBL] [Abstract][Full Text] [Related]
6. Co-trimoxazole versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus bacteraemia: a retrospective cohort study.
Goldberg E; Paul M; Talker O; Samra Z; Raskin M; Hazzan R; Leibovici L; Bishara J
J Antimicrob Chemother; 2010 Aug; 65(8):1779-83. PubMed ID: 20507860
[TBL] [Abstract][Full Text] [Related]
7. High vancomycin minimum inhibitory concentration is a predictor of mortality in meticillin-resistant Staphylococcus aureus bacteraemia.
Wi YM; Kim JM; Joo EJ; Ha YE; Kang CI; Ko KS; Chung DR; Song JH; Peck KR
Int J Antimicrob Agents; 2012 Aug; 40(2):108-13. PubMed ID: 22633565
[TBL] [Abstract][Full Text] [Related]
8. [Bacteraemia at a second level hospital: epidemiological study, analysis of pronostic factors associated to mortality and economic cost estimation].
Hernández-Roca JJ; García-Vázquez E; Hernández A; Canteras M; Herrero JA; Cascales E; Mené-Fenor E; Gómez-Gómez J
Rev Esp Quimioter; 2013 Jun; 26(2):119-27. PubMed ID: 23817650
[TBL] [Abstract][Full Text] [Related]
9. [Comparative study of meningitis due to Staphylococcus aureus and coagulase-negative Staphylococci in adults].
Laguna-Del Estal P; Castañeda-Pastor A; Gil-Navarro M; García-Madero R; López-Cano Gómez M; Agud-Fernández M
Rev Neurol; 2009 Jan 1-15; 48(1):2-6. PubMed ID: 19145558
[TBL] [Abstract][Full Text] [Related]
10. [Staphylococcus aureus sepsis in hospitalized non neutropenic patients: retrospective clinical and microbiological analysis].
Falcone M; Carfagna P; Cassone M; Pistella E; Pavoni G; Nofroni I; Serra P; Venditti M
Ann Ital Med Int; 2002; 17(3):166-72. PubMed ID: 12402664
[TBL] [Abstract][Full Text] [Related]
11. Coagulase-negative Staphylococcus bacteraemia accounts for one third of Staphylococcus bacteraemia in a French university hospital.
N'Guyen Y; Baumard S; Vernet-Garnier V; Batalla AS; de Champs C; Jaussaud R; Strady C
Scand J Infect Dis; 2012 Feb; 44(2):79-85. PubMed ID: 22017739
[TBL] [Abstract][Full Text] [Related]
12. Site of infection rather than vancomycin MIC predicts vancomycin treatment failure in methicillin-resistant Staphylococcus aureus bacteraemia.
Walraven CJ; North MS; Marr-Lyon L; Deming P; Sakoulas G; Mercier RC
J Antimicrob Chemother; 2011 Oct; 66(10):2386-92. PubMed ID: 21775337
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for mortality in patients with persistent methicillin-resistant Staphylococcus aureus bacteraemia in a tertiary care hospital in Taiwan.
Lin SH; Liao WH; Lai CC; Liao CH; Tan CK; Wang CY; Huang YT; Hsueh PR
J Antimicrob Chemother; 2010 Aug; 65(8):1792-8. PubMed ID: 20511366
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology of bacteraemia in Hamad general hospital, Qatar: a one year hospital-based study.
Khan FY; Elshafie SS; Almaslamani M; Abu-Khattab M; El Hiday AH; Errayes M; Almaslamani E
Travel Med Infect Dis; 2010 Nov; 8(6):377-87. PubMed ID: 21074495
[TBL] [Abstract][Full Text] [Related]
15. Predictors of mortality in patients with methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia: the role of empiric antibiotic therapy.
Gómez J; García-Vázquez E; Baños R; Canteras M; Ruiz J; Baños V; Herrero JA; Valdés M
Eur J Clin Microbiol Infect Dis; 2007 Apr; 26(4):239-45. PubMed ID: 17318479
[TBL] [Abstract][Full Text] [Related]
16. Predisposing factors, disease progression and outcome in 430 prospectively followed patients of healthcare- and community-associated Staphylococcus aureus bacteraemia.
Forsblom E; Ruotsalainen E; Mölkänen T; Ollgren J; Lyytikäinen O; Järvinen A
J Hosp Infect; 2011 Jun; 78(2):102-7. PubMed ID: 21511366
[TBL] [Abstract][Full Text] [Related]
17. Persistent bacteremia and severe thrombocytopenia caused by coagulase-negative Staphylococcus in a neonatal intensive care unit.
Khashu M; Osiovich H; Henry D; Al Khotani A; Solimano A; Speert DP
Pediatrics; 2006 Feb; 117(2):340-8. PubMed ID: 16452352
[TBL] [Abstract][Full Text] [Related]
18. Staphylococcus aureus bacteraemia--Nationwide assessment of treatment adequacy and outcome.
Asgeirsson H; Kristjansson M; Kristinsson KG; Gudlaugsson O
J Infect; 2011 May; 62(5):339-46. PubMed ID: 21402101
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors associated with 30-day in-hospital mortality in coagulase-negative Staphylococcus bacteraemia: no impact of vancomycin minimum inhibitory concentration.
Hentzien M; Strady C; Vernet-Garnier V; Servettaz A; De Champs C; Delmer A; Bani-Sadr F; N'Guyen Y
Infect Dis (Lond); 2017 Sep; 49(9):664-673. PubMed ID: 28490261
[TBL] [Abstract][Full Text] [Related]
20. Levofloxacin does not decrease mortality in Staphylococcus aureus bacteraemia when added to the standard treatment: a prospective and randomized clinical trial of 381 patients.
Ruotsalainen E; Järvinen A; Koivula I; Kauma H; Rintala E; Lumio J; Kotilainen P; Vaara M; Nikoskelainen J; Valtonen V;
J Intern Med; 2006 Feb; 259(2):179-90. PubMed ID: 16420547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
